Sun Pharmaceutical shareholders approved the appointment of Ms. Satyavati Berera as an Independent Director via postal ballot.
Ms. Berera's term is for five years, effective from 08 May 2026.
The voting results and Scrutinizer's Report have been submitted to the stock exchanges and made available on the company website.